html5 templates

Dr Ravi Suppiah's recent publications


Peer reviewed articles:

1. Seeliger B, Sznajd J, Robson JC, Judge A, Craven A, Grayson PC, Suppiah RS, et al. Are the 1990 American College of Rheumatology vasculitis classification criteria still valid? Rheumatology (Oxford). 2017 Jul 1;56(7):1154-1161.

2. Baraliakos X, Heldmann F, Callhoff J, Suppiah R, McQueen FM, Krausse D, et al., Quantification of Bone Marrow Edema by Magnetic Resonance Imaging Only Marginally Reflects Clinical Neck Pain Evaluation in Rheumatoid Arthritis and Ankylosing Spondylitis. J Rheumatol. 2016 Dec;43(12):2131-2135.

3. Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Hoglund P, et al., Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials. Rheumatology (Oxford), 2015

4. Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Hoglund P, et al., Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials. Ann Rheum Dis, 2015

5. Teoh L, Suppiah R, Gow P. Late-onset rheumatoid arthritis in the Counties Manukau District Health Board region of New Zealand: an observational study of treatment. N Z Med J. 2014 Dec 19;127(1407):40-8.

6. Suppiah R., Outcome Measures in systemic vasculitis. Indian Journal of Rheumatology, 2013, Vol 8, Suppl 1, S61–S67.

7. Craven A, Robson J, Ponte C, Grayson P C, Suppiah R, Judge A, et al., ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS). Clin Exp Nephrol, 2013. 17(5): p. 619-21

8. Kumar S, Gupta R, Suppiah R, Gout in women: differences in risk factors in young and older women. N Z Med J, 2012. 125(1363): p. 39-45.

9. Wilsher, M., Good, N., Hopkins, R., Young, P., Milne, D., Gibson, A., Suppiah, R., Ly, J., Doughty, R., and Dalbeth, N., The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease. Respirology, 2012. 17(4): p. 647-52.

10. Direskeneli, H., Aydin, S.Z., Kermani, T.A., Matteson, E.L., Boers, M., Herlyn, K., Luqmani, R.A., Neogi, T., Seo, P., Suppiah, R., et al., Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda. J Rheumatol, 2011. 38(7): p. 1471-9.

11. Luqmani, R., Suppiah, R., Edwards, C.J., Phillip, R., Maskell, J., Culliford, D., Jayne, D., Morishita, K., and Arden, N., Mortality in Wegener's granulomatosis: a bimodal pattern. Rheumatology (Oxford), 2011. 50(4): p. 697-702.

12. Luqmani, R.A., Suppiah, R., Grayson, P.C., Merkel, P.A., and Watts, R., Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS). Clin Exp Immunol, 2011. 164 Suppl 1: p. 11-3.

13. Merkel, P.A., Aydin, S.Z., Boers, M., Direskeneli, H., Herlyn, K., Seo, P., Suppiah, R., Tomasson, G., and Luqmani, R.A., The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. J Rheumatol, 2011. 38(7): p. 1480-6.

14. Suppiah, R., Flossman, O., Mukhtyar, C., Alberici, F., Baslund, B., Brown, D., Hasan, N., Holle, J., Hruskova, Z., Jayne, D., et al., Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index. Ann Rheum Dis, 2011. 70(1): p. 80-5.

15. Suppiah, R., Hadden, R.D., Batra, R., Arden, N.K., Collins, M.P., Guillevin, L., Jayne, D.R., Luqmani, R.A., and European Vasculitis Study, G., Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Rheumatology (Oxford), 2011. 50(12): p. 2214-22.

16. Suppiah, R., Judge, A., Batra, R., Flossmann, O., Harper, L., Hoglund, P., Javaid, M.K., Jayne, D., Mukhtyar, C., Westman, K., et al., A model to predict cardiovascular events in patients with newly diagnosed wegener's granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken), 2011.

17. Suppiah, R., Mukhtyar, C., Flossmann, O., Alberici, F., Baslund, B., Batra, R., Brown, D., Holle, J., Hruskova, Z., Jayne, D.R., et al., A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford), 2011. 50(5): p. 899-905.

18. Suppiah, R., Robson, J., Basu, N., and Luqmani, R., The Need for Diagnostic Criteria in Systemic Vasculitis. Current Immunology Reviews, 2011. 7(4): p. 394-401.

19. Teh, J., Suppiah, R., Sharp, R., and Newton, J., Imaging in the assessment and management of overuse injuries in the foot and ankle. Semin Musculoskelet Radiol, 2011. 15(1): p. 101-14.

20. Watts, R.A., Suppiah, R., Merkel, P.A., and Luqmani, R., Systemic vasculitis--is it time to reclassify? Rheumatology (Oxford), 2011. 50(4): p. 643-5.

21. Suppiah, R., Robson, J., and Luqmani, R., Outcome measures in ANCA-associated vasculitis. Rheum Dis Clin North Am, 2010. 36(3): p. 587-607.

22. Suppiah, R., Doyle, A., Rai, R., Dalbeth, N., Lobo, M., Braun, J., and McQueen, F.M., Quantifying bone marrow edema in the rheumatoid cervical spine using magnetic resonance imaging. J Rheumatol, 2010. 37(8): p. 1626-32.

23. Suppiah, R., Mee, E., Walker, E.B., Roberts, L., Finucane, G., and Bergin, P.S., Temporal lobe resection for refractory temporal lobe epilepsy at Auckland Hospital. N Z Med J, 2009. 122(1305): p. 47-56.

24. Suppiah R, Robson J, Guillevin L, Luqmani R. Polyarteritis nodosa. BMJ Point-of-Care 2009; www.pointofcare.bmj.com.

25. Suppiah R, Basu N, Watts R, Luqmani R. Advances in the Classification of Primary Systemic Vasculitis. Int J Adv Rheumatol 2009;7(1):12-20.

26. Suppiah, R., Dissanayake, A., and Dalbeth, N., High prevalence of gout in patients with Type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors. N Z Med J, 2008. 121(1283): p. 43-50.

27. Suppiah, R. and McQueen, F., Hypertrophic osteoarthropathy associated with a left ventricular tumour. Rheumatology (Oxford), 2008. 47(9): p. 1277.



Book Chapters

1. Robson J, Suppiah R, Luqmani R. Systemic vasculitis. Chapter in: Medical Research: Understanding the studies that shaped medicine. Wiley-Blackwell, Oxford.

2. Robson J, Suppiah R, Luqmani R. Assessment of disease activity and damage in the ANCA associated systemic vasculitides. Chapter in: Rheumatology and the Kidney 2nd Edition. Oxford University Press.

3. Luqmani R, Robson J and Suppiah R. Vasculitis. Chapter in: Oxford diagnosis and treatment in internal medicine. Oxford University Press.



International Conference presentations


1. Suppiah R, Grayson P, Ponte C on behalf of the DCVAS working Group.  Updated Classification Criteria for Large-Vessel Vasculitis.

• Invited Speaker, 90 minute symposium, ACR 2018, Chicago USA

2. Robson J, Ponte P, Grayson P, Suppiah R, Merkel PA, Watts RA, on behalf of the DCVAS working group. New Classification Criteria for the ANCA-Associated Vasculitides in the Age of ANCA

• Invited Speaker, 60 minute symposium, ACR 2017, San Diego, USA.

3. Suppiah R, Grayson P, Ponte C, Robson J, Merkel PA, Watts RA, Luqmani RA on behalf of the DCVAS working group. Clinical symposium - New Classification Criteria for ANCA-Associated Vasculitis: Implications for Clinical Practice.

• Invited Speaker, 90 minute symposium, ACR 2016, Washington DC, USA.

4. Benjamin Seeliger, Andrew Judge, Jan Sznajd, Peter A. Merkel, Richard Watts, Ravi Suppiah, Joanna C. Robson, Peter C. Grayson, Anthea Craven, Raashid A. Luqmani. Re-appraisal of the 1990 American College of Rheumatology (ACR) Classification Criteria for Systemic Vasculitis - Analysis of data from the Diagnostic & Classification Criteria in Vasculitis Study (DCVAS)

• Oral presentation, ANCA workshop 2015, London, UK

5. Ponte C, Rodrigues A, Prieto-González S, Alba MA, Geraldes R, Craven A, Judge A, Grayson PC, Suppiah R, Robson J, Watts RA, Merkel PA, Cid MC, Luqmani RA, on behalf of the DCVAS Investigators. The use of Positron Emission Tomography (PET) in patients with Giant Cell Arteritis (GCA): analysis of data from the Diagnostic and Classification Criteria for Vasculitis (DVAS) Study

• Oral Presentation, EULAR 2015, London, UK

6. Pearce FA, Craven A, Robson J, Luqmani RA, Grayson PC, Merkel PA, Suppiah R, Watts RA. Ethnic and geographic differences in the phenotype of ANCA associated vasculitis (AAV) - preliminary data from the DCVAS study

• Oral Presentation, ANCA workshop 2015, London, UK

7. Ponte C, Grayson, PC, Suppiah R, Robson J, Craven A, Judge A, Merkel PA, Watts RA, Luqmani RA on behalf of the DCVAS working group. Colour Doppler Ultrasonography Findings in Giant Cell Arteritis (GCA) and Their Relationship with Clinical Manifestations: Analysis of Data from the Diagnostic and Classification Criteria for Vasculitis (DCVAS) Study.

• Poster presentation, ACR, Nov 2014, Boston, USA.

8. Ponte C, Grayson, PC, Suppiah R, Robson J, Craven A, Judge A, Merkel PA, Watts RA, Luqmani RA on behalf of the DCVAS working group. Development of the classification criteria for Giant Cell Arteritis in the diagnostic and classification criteria for vasculitis study: A pilot study using a panel review methodology

• Poster presentation, EULAR 2014, Paris, France

9. Ponte C, Craven A, Robson J, Grayson PC, Suppiah R, Watts RA, Merkel PA, Luqmani RA. Review Of The Expert Panel Methodology In The Diagnostic and Classification Criteria For Vasculitis Study: A Pilot Study

• Oral Presentation, ACR 2014, San Diego, USA

10. Geraldes, R, Fonseca AC, Canhão P, Pinho e Melo T, Ferro J, Watts R, Merkel P, Grayson P, Robson J, Craven A, Suppiah R, Luqmani R. Stroke in primary systemic vasculitis: DCVAS stroke substudy

• Poster presentation – ESC, May 2013, London, UK

11. Suppiah R, Hadden RD, Batra R, Collins MP, Guillevin L, Jayne DR., Luqmani RA. Peripheral neuropathy in ANCA-AAV

• Poster presentation – 15th International Vasculitis and ANCA Workshop 2011, Chapel Hill, USA

12. Suppiah R, Judge A, Batra R, Javaid M K, Jayne D, Seo P, Luqmani R. Predicting cardiovascular events in patients with newly diagnosed ANCA-AAV

• Poster presentation – 15th International Vasculitis and ANCA Workshop 2011, Chapel Hill, USA

13. Suppiah R Batra R, Robson J, Hoglund P, Jayne D, Westman K, Luqmani R. The prognostic value of BVAS and VDI in ANCA-AAV

• Poster presentation – 15th International Vasculitis and ANCA Workshop 2011, Chapel Hill, USA

14. Suppiah R, Teh J, Newton J. Ischio-femoral impingement seen on MRI of the hip or pelvis in athletes: What is the clinical significance?

• Poster presentation - BASEM 2010, London, UK.

15. Jones N, Suppiah R, Newton J. Correlation between physical activity in patients with inflammatory arthritis and beliefs about aerobic exercise: A pilot study.

• Poster presentation - BSR 2010, Birmingham UK and BASEM 2010, London, UK.

16. Suppiah R, Doyle A, Rai R, et al. Lessons learned from quantifying bone marrow oedema in the rheumatoid cervical spine.

• Poster presentation - BSR 2010, Birmingham, UK.

17. Suppiah R, Judge A, Batra R, et al. A model to predict cardiovascular events in patients with newly diagnosed Wegener’s granulomatosis and microscopic polyangiitis.

• Poster presentation - BSR 2010, Birmingham, UK and EULAR 2010, Rome, Italy.

18. Luqmani R, Suppiah R, Edwards C et al. Mortality in Wegener’s Granulomatosis: a bimodal pattern.

• Poster presentation - EULAR 2010, Rome, Italy.

19. Suppiah R, Flossmann O, Mukhtyar C, et al. Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index (VDI) with the Combined Damage Assessment Index.

• Poster presentation - ACR 2009, Philadelphia, USA and BSR 2010, Birmingham, UK.

© Copyright 2011-2019 Auckland Rheumatology and Sports Medicine Limited